Genomics in Scotland strategy: business and regulatory impact assessment

Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).


15. Declaration and Publication

I have read the Business and Regulatory Impact Assessment, and I am satisfied that (a) it represents a fair and reasonable view of the expected costs, benefits and impact of the policy, and (b) that the benefits justify the costs. I am satisfied that business impact has been assessed with the support of businesses in Scotland.

Signed:

Date:

Minister’s name: Neil Gray

Minister’s title: Cabinet Secretary for NHS Recovery, Health and Social Care

Scottish Government Contact point: holly.ennis@gov.scot

Contact

Email: holly.ennis@gov.scot

Back to top